These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20828393)

  • 1. Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination.
    St Germain C; O'Brien A; Dimitroulakos J
    Cancer Cell Int; 2010 Sep; 10():32. PubMed ID: 20828393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells.
    Weberpals JI; O'Brien AM; Niknejad N; Garbuio KD; Clark-Knowles KV; Dimitroulakos J
    Cancer Cell Int; 2011 Aug; 11(1):29. PubMed ID: 21854619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.
    St Germain C; Niknejad N; Ma L; Garbuio K; Hai T; Dimitroulakos J
    Neoplasia; 2010 Jul; 12(7):527-38. PubMed ID: 20651982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.
    O'Brien A; Barber JE; Reid S; Niknejad N; Dimitroulakos J
    Anticancer Res; 2012 Jul; 32(7):2679-88. PubMed ID: 22753726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.
    Bar J; Hasim MS; Baghai T; Niknejad N; Perkins TJ; Stewart DJ; Sekhon HS; Villeneuve PJ; Dimitroulakos J
    Neoplasia; 2016 Sep; 18(9):525-35. PubMed ID: 27659012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
    Niknejad N; Gorn-Hondermann I; Ma L; Zahr S; Johnson-Obeseki S; Corsten M; Dimitroulakos J
    Int J Cancer; 2014 Jan; 134(2):268-79. PubMed ID: 23824972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.
    Li X; Chen BD
    Am J Biomed Sci; 2009 Jun; 1(4):352-363. PubMed ID: 20526416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer.
    Hasim MS; Nessim C; Villeneuve PJ; Vanderhyden BC; Dimitroulakos J
    Transl Oncol; 2018 Aug; 11(4):988-998. PubMed ID: 29940414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.
    Yeung A; Bhargava RK; Ahn R; Bahna S; Kang NH; Lacoul A; Niles LP
    Biomed Pharmacother; 2012 Apr; 66(3):232-6. PubMed ID: 22436652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
    Riessland M; Brichta L; Hahnen E; Wirth B
    Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
    Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
    Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis upon potassium usnate exposure reveals ATF3-induced apoptosis in human gastric and colon cancer cells.
    Yoo KH; Kim DH; Oh S; Park MS; Kim H; Ha HH; Cho SH; Chung IJ; Bae WK
    Phytomedicine; 2021 Oct; 91():153655. PubMed ID: 34388563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells.
    Liu J; Edagawa M; Goshima H; Inoue M; Yagita H; Liu Z; Kitajima S
    Biochem Biophys Res Commun; 2014 Mar; 445(2):320-6. PubMed ID: 24530917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses.
    Hamdi M; Popeijus HE; Carlotti F; Janssen JM; van der Burgt C; Cornelissen-Steijger P; van de Water B; Hoeben RC; Matsuo K; van Dam H
    DNA Repair (Amst); 2008 Mar; 7(3):487-96. PubMed ID: 18249159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG1 Downregulates ATF3 and Inhibits Cisplatin-Induced Cytotoxicity in Lung Cancer A549 Cells.
    Du A; Jiang Y; Fan C
    Int J Med Sci; 2018; 15(13):1502-1507. PubMed ID: 30443171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
    Bandolik JJ; Hamacher A; Schrenk C; Weishaupt R; Kassack MU
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOXA upregulation by the prohibitin-binding compound fluorizoline is transcriptionally regulated by integrated stress response-induced ATF3 and ATF4.
    Núñez-Vázquez S; Sánchez-Vera I; Saura-Esteller J; Cosialls AM; Noisier AFM; Albericio F; Lavilla R; Pons G; Iglesias-Serret D; Gil J
    FEBS J; 2021 Feb; 288(4):1271-1285. PubMed ID: 32648994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
    Jin KL; Park JY; Noh EJ; Hoe KL; Lee JH; Kim JH; Nam JH
    J Gynecol Oncol; 2010 Dec; 21(4):262-8. PubMed ID: 21278889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells.
    Hao ZF; Su YM; Wang CM; Yang RY
    Tumour Biol; 2015 Mar; 36(3):1471-6. PubMed ID: 25371069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.